speb/financial-data huggingface dataset:
Financial ratios for MLSEQ.PA — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -2531.645569620253
Operating income: -4543037.974683544
Net income: -4616455.696202531
Capital expenditures: 0
Operating cash flow: -5172151.8987341765
Depreciation & amortization: 2531.645569620253
Net tangible assets: 9212658.227848101
Owner earnings: -4613924.050632911
Return on net tangible assets (%): -50.08244023083264
Buffett classification: The Gruesome
Stock price: 0.011111111111111112
Shares outstanding: 956666548
Book value: 9212658.2278481
P/B ratio: 1.1538068653170899
Market cap (USD): 10629628.311111111
Debt to equity: 0
Current ratio: 13.06965174129353
Quick ratio: 13.06965174129353
Interest coverage ratio: -61.87931034482758
Free cash flow (dilution-adjusted): -5172151.8987341765
Buyback yield (%): 0
Retained earnings: -396036708.8607595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.312998076394614
Rule of 40 score: 0
Financial ratios for MML.AX — annual report dated 2022-06-30
Operating income: -521253.7931034483
Net income: -614579.3103448276
Capital expenditures: 10708.96551724138
Depreciation & amortization: 594.4827586206897
Net tangible assets: 3953673.7931034486
Owner earnings: -624693.7931034483
Return on net tangible assets (%): -15.800337250714177
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
Shares outstanding: 505461159
Book value: 3953673.7931034486
P/B ratio: 7.0535693332451865
Market cap (USD): 27887512.220689658
Debt to equity: 0
Current ratio: 65.29815419387242
Quick ratio: 65.29815419387242
Free cash flow (dilution-adjusted): -715215.1724137932
Buyback yield (%): 0.9301135045274566
Retained earnings: -640662.0689655172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.184036427403093
Rule of 40 score: 0
Financial ratios for MML.AX — annual report dated 2023-06-30
Operating income: -1152086.0927152317
Net income: -1090010.59602649
Capital expenditures: 6468.87417218543
Depreciation & amortization: 3191.390728476821
Net tangible assets: 2744796.6887417217
Owner earnings: -1093288.0794701984
Return on net tangible assets (%): -39.83129548190277
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 505461159
Book value: 2744796.6887417217
P/B ratio: 7.31731768936432
Market cap (USD): 20084549.36423841
Debt to equity: 0.038644341623633206
Current ratio: 16.982738903580874
Quick ratio: 16.982738903580874
Free cash flow (dilution-adjusted): -1148003.9735099338
Buyback yield (%): 0
Retained earnings: -1705215.8940397352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.75549653930277
Rule of 40 score: 0
Financial ratios for NAMS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 18012.602272727272
Buffett classification: The Gruesome
Stock price: 9.75
Shares outstanding: 116903979
Market cap (USD): 1139813795.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAMS — annual report dated 2022-12-31
Total revenue: 109248936.17021278
Operating income: -3784042.5531914895
Net income: -24078723.40425532
Capital expenditures: 235106.3829787234
Operating cash flow: 11345744.680851065
Depreciation & amortization: 82141.08510638298
Net tangible assets: 457295744.6808511
Owner earnings: -24231688.702127658
Return on net tangible assets (%): -5.298909728328889
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 116903979
Book value: 457517021.2765958
P/B ratio: 2.7851496487376357
Market cap (USD): 1274253371.1000001
Debt to equity: 0.00029297828705361504
Current ratio: 13.256205452478019
Quick ratio: 13.256205452478019
Interest coverage ratio: -12.393728222996517
COGS to revenue (%): 0
R&D to revenue (%): 84.4684207451263
SG&A to revenue (%): 18.995267493719204
Free cash flow (dilution-adjusted): 6730851.063829787
Buyback yield (%): 0
Retained earnings: -148974468.0851064
Receivables turnover: 49.61062801932368
Capitalized R&D asset: 92280851.0638298
ROCI (R&D-adjusted, %): 10.255853036624941
FCF margin (%): 6.161022065553976
Rule of 40 score: 6.161022065553976
Financial ratios for NAMS — annual report dated 2023-12-31
Total revenue: 15655555.555555556
Operating income: -203296666.66666666
Net income: -196596666.66666666
Capital expenditures: 26666.666666666664
Operating cash flow: -156908888.8888889
Depreciation & amortization: 54444.444444444445
Net tangible assets: 320247777.7777778
Owner earnings: -196568888.88888887
Return on net tangible assets (%): -61.38025070865266
Buffett classification: The Gruesome
Stock price: 11.17
Shares outstanding: 116903979
Book value: 320436666.6666666
P/B ratio: 4.075118677939479
Market cap (USD): 1305817445.43
Debt to equity: 0.00020804943254517277
Current ratio: 6.950137282802573
Quick ratio: 6.950137282802573
COGS to revenue (%): 0
R&D to revenue (%): 1131.4691270404542
SG&A to revenue (%): 267.09013484740944
Free cash flow (dilution-adjusted): -184237777.77777776
Buyback yield (%): 0
Retained earnings: -352192222.2222222
Receivables turnover: 7.49069643806486
Capitalized R&D asset: 238965947.99054372
ROCI (R&D-adjusted, %): -20.373771728145655
FCF margin (%): -1176.820440028389
Revenue growth (%): -85.66983249048414
Rule of 40 score: -1262.490272518873
Financial ratios for NAMS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.6
Shares outstanding: 116903979
Market cap (USD): 1940606051.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAMS — annual report dated 2024-12-31
Total revenue: 47461458.333333336
Operating income: -183634375
Net income: -251664583.33333334
Capital expenditures: 700000
Operating cash flow: -165170833.33333334
Depreciation & amortization: 117708.33333333334
Net tangible assets: 788506250
Owner earnings: -252246875
Return on net tangible assets (%): -31.990472491498956
Buffett classification: The Gruesome
Stock price: 25.7
Shares outstanding: 116903979
Book value: 789062500
P/B ratio: 3.8075973199841586
Market cap (USD): 3004432260.2999997
Debt to equity: 0.0005914191419141915
Current ratio: 8.075469051048467
Quick ratio: 8.075469051048467
COGS to revenue (%): 0
R&D to revenue (%): 332.3003314092575
SG&A to revenue (%): 154.61229506397734
Free cash flow (dilution-adjusted): -200890625
Buyback yield (%): 0
Retained earnings: -581844791.6666667
Receivables turnover: 2.1386059610420087
Capitalized R&D asset: 306849575.29550827
ROCI (R&D-adjusted, %): -15.353897971479746
FCF margin (%): -423.2710752145381
Revenue growth (%): 203.16048616039745
Rule of 40 score: -220.11058905414063
Financial ratios for NAMS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.7
Shares outstanding: 116903979
Market cap (USD): 3004432260.2999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAMS — quarterly report dated 2025-03-31
Total revenue: 3236956.5217391304
Operating income: -74918478.26086956
Net income: -42964130.43478261
Capital expenditures: 17391.304347826088
Operating cash flow: -39639130.43478261
Depreciation & amortization: 56521.73913043478
Net tangible assets: 844414130.4347826
Owner earnings: -42925000
Return on net tangible assets (%): -5.083406169185993
Buffett classification: The Gruesome
Stock price: 20.47
Shares outstanding: 116903979
Book value: 844959782.6086956
P/B ratio: 2.8321163910806146
Market cap (USD): 2393024450.1299996
Debt to equity: 0.0005004097184970214
Current ratio: 19.976633343924917
Quick ratio: 19.976633343924917
COGS to revenue (%): 0
R&D to revenue (%): 1502.719946272666
SG&A to revenue (%): 911.7528542646071
Free cash flow (dilution-adjusted): -56192391.30434782
Buyback yield (%): 0
Retained earnings: -650106521.7391304
Receivables turnover: 1.8462492250464972
Capitalized R&D asset: 48642391.30434782
ROCI (R&D-adjusted, %): -4.75414441575626
FCF margin (%): -1735.9637340496977
Rule of 40 score: -1735.9637340496977
Financial ratios for NAMS — quarterly report dated 2025-06-30
Total revenue: 3192562.635294118
Operating income: -41923529.4117647
Net income: -20428235.29411765
Capital expenditures: 103529.41176470589
Operating cash flow: -44318823.52941176
Depreciation & amortization: 52941.17647058824
Net tangible assets: 915325882.3529412
Owner earnings: -20478823.529411767
Return on net tangible assets (%): -2.237325953983602
Buffett classification: The Gruesome
Stock price: 18.11
Shares outstanding: 116903979
Book value: 915878823.5294118
P/B ratio: 2.3115842459720457
Market cap (USD): 2117131059.6899998
Debt to equity: 0.0004213246807630601
Current ratio: 21.084848816827343
Quick ratio: 21.084848816827343
COGS to revenue (%): 0
R&D to revenue (%): 1013.9743022739497
SG&A to revenue (%): 1004.6880134175376
Free cash flow (dilution-adjusted): -62280000
Buyback yield (%): 0
Retained earnings: -724072941.1764706
Receivables turnover: 0.13740142987341775
Capitalized R&D asset: 64962166.8797954
ROCI (R&D-adjusted, %): -3.7265946241572654
FCF margin (%): -1950.7839661934274
Revenue growth (%): -1.3714699640500811
Rule of 40 score: -1952.1554361574774
Financial ratios for NAMS — quarterly report dated 2025-09-30
Total revenue: 409411.76470588235
Operating income: -64874117.64705882
Net income: -84711764.70588236
Capital expenditures: 49411.76470588236
Operating cash flow: -38551764.705882356
Depreciation & amortization: 75294.11764705883
Net tangible assets: 856036470.5882353
Owner earnings: -84685882.35294119
Return on net tangible assets (%): -9.89278906478696
Buffett classification: The Gruesome
Stock price: 28.44
Shares outstanding: 116903979
Book value: 856552941.1764706
P/B ratio: 3.881545439787383
Market cap (USD): 3324749162.76
Debt to equity: 0.0003653494856263821
Current ratio: 12.567408017572761
Quick ratio: 12.567408017572761
COGS to revenue (%): 0
R&D to revenue (%): 8899.712643678162
SG&A to revenue (%): 7045.977011494253
Free cash flow (dilution-adjusted): -56260000
Buyback yield (%): 0
Retained earnings: -808784705.882353
Receivables turnover: 0.017186033878216208
Capitalized R&D asset: 74177542.07161126
ROCI (R&D-adjusted, %): -7.261027345079478
FCF margin (%): -13741.666666666666
Revenue growth (%): -87.17607729352615
Rule of 40 score: -13828.842743960193
Financial ratios for NAMS — annual report dated 2025-12-31
Total revenue: 26474117.647058826
Operating income: -265509411.7647059
Net income: -239787058.82352942
Capital expenditures: 289411.76470588235
Operating cash flow: -173862352.94117647
Depreciation & amortization: 258823.5294117647
Net tangible assets: 803557647.0588236
Owner earnings: -239817647.05882356
Return on net tangible assets (%): -29.844485698891987
Buffett classification: The Gruesome
Stock price: 35.08
Shares outstanding: 116903979
Book value: 804036470.5882353
P/B ratio: 5.100504433983826
Market cap (USD): 4100991583.3199997
Debt to equity: 0.00029556751157029757
Current ratio: 7.876484782076537
Quick ratio: 7.876484782076537
COGS to revenue (%): 0
R&D to revenue (%): 630.2804070568368
SG&A to revenue (%): 472.62142825401054
Free cash flow (dilution-adjusted): -244063529.41176474
Buyback yield (%): 0
Retained earnings: -896929411.7647059
Receivables turnover: 0.9719678645473394
Capitalized R&D asset: 330985413.97058827
ROCI (R&D-adjusted, %): -23.424032320387443
FCF margin (%): -921.894858463316
Revenue growth (%): -44.21975519352002
Rule of 40 score: -966.114613656836
Financial ratios for NAMS — quarterly report dated 2025-12-31
Total revenue: 37647.05882352941
Operating income: -77623529.41176471
Net income: -88144705.88235295
Capital expenditures: 117647.05882352941
Operating cash flow: -48088235.29411765
Depreciation & amortization: 69411.76470588235
Net tangible assets: 803557647.0588236
Owner earnings: -88192941.1764706
Return on net tangible assets (%): -10.975309798777202
Buffett classification: The Gruesome
Stock price: 35.08
Shares outstanding: 116903979
Book value: 804036470.5882353
P/B ratio: 5.100504433983826
Market cap (USD): 4100991583.3199997
Debt to equity: 0.00029556751157029757
Current ratio: 7.876484782076537
Quick ratio: 7.876484782076537
COGS to revenue (%): 0
R&D to revenue (%): 120606.25
SG&A to revenue (%): 85681.25
Free cash flow (dilution-adjusted): -64703529.41176471
Buyback yield (%): 0
Retained earnings: -896929411.7647059
Receivables turnover: 0.00138217000691085
Capitalized R&D asset: 80499823.52941176
ROCI (R&D-adjusted, %): -7.945816886865748
FCF margin (%): -171868.75
Revenue growth (%): -90.80459770114942
Rule of 40 score: -171959.55459770115
Financial ratios for NG — annual report dated 2021-11-30
Capital expenditures: 0
Depreciation & amortization: 738582.6771653544
Buffett classification: The Gruesome
Stock price: 6.75
Shares outstanding: 438780614
Market cap (USD): 2961769144.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NG — annual report dated 2022-11-30
Total revenue: 0
Gross profit: -5147.058823529412
Operating income: -14430882.352941176
Net income: -39222794.11764706
Capital expenditures: 0
Operating cash flow: -9096323.529411765
Net tangible assets: 21987500
Owner earnings: -39222794.11764706
Return on net tangible assets (%): -178.38678393472227
Buffett classification: The Gruesome
Stock price: 5.77
Shares outstanding: 438780614
Book value: 21987500
P/B ratio: 115.14561195133598
Market cap (USD): 2531764142.7799997
Debt to equity: 4.167775808447312
Current ratio: 33.167645140247885
Quick ratio: 33.167645140247885
Interest coverage ratio: -2.4649585531273552
Free cash flow (dilution-adjusted): -15136029.411764706
Buyback yield (%): 0
Retained earnings: -1479785294.117647
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.695517174461479
Rule of 40 score: 0
Financial ratios for NG — annual report dated 2023-11-30
Total revenue: 0
Gross profit: -7352.941176470587
Operating income: -15988970.588235293
Net income: -34413970.58823529
Capital expenditures: 408823.5294117647
Operating cash flow: -5725000
Net tangible assets: -6046323.529411764
Owner earnings: -34822794.11764705
Buffett classification: The Gruesome
Stock price: 4.2
Shares outstanding: 438780614
Book value: -6046323.529411763
Market cap (USD): 1842878578.8000002
Debt to equity: -16.727350115529617
Current ratio: 32.57014848950333
Quick ratio: 32.57014848950333
Interest coverage ratio: -1.6646252775013395
Free cash flow (dilution-adjusted): -12144852.94117647
Buyback yield (%): 0
Retained earnings: -1514199264.7058823
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.80656031657701
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.25
Shares outstanding: 438780614
Market cap (USD): 1864817609.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 438780614
Market cap (USD): 1605937047.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NG — annual report dated 2024-11-30
Total revenue: 0
Gross profit: -15714.285714285716
Operating income: -18053571.42857143
Net income: -32586428.571428575
Capital expenditures: 530714.2857142858
Operating cash flow: -9030000
Net tangible assets: -33868571.42857143
Owner earnings: -33117142.857142862
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 438780614
Book value: -33868571.42857143
Market cap (USD): 1605937047.24
Debt to equity: -3.215201619706428
Current ratio: 22.905483727151136
Quick ratio: 22.905483727151136
Interest coverage ratio: -1.7107756870177337
Free cash flow (dilution-adjusted): -14199285.714285715
Buyback yield (%): 0
Retained earnings: -1503522857.1428573
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.01037362136282
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -4166.666666666667
Operating income: -3334722.2222222225
Net income: -6330555.555555556
Capital expenditures: 0
Operating cash flow: -3791666.666666667
Net tangible assets: -38976388.88888889
Owner earnings: -6330555.555555556
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 438780614
Book value: -38976388.88888888
Market cap (USD): 1316341842
Debt to equity: -2.778908170901187
Current ratio: 47.8211217786761
Quick ratio: 47.8211217786761
Interest coverage ratio: -1.3466068424004487
Free cash flow (dilution-adjusted): -4474305.555555556
Buyback yield (%): 0
Retained earnings: -1468088888.8888888
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.799696145849992
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2025-05-31
Total revenue: 0
Gross profit: -3623.188405797102
Operating income: -4203623.188405798
Net income: -39329710.14492754
Capital expenditures: 0
Operating cash flow: -1180434.7826086958
Net tangible assets: 119765942.02898552
Owner earnings: -39329710.14492754
Return on net tangible assets (%): -32.83880999776134
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 438780614
Book value: 119765942.0289855
P/B ratio: 13.115870601508984
Market cap (USD): 1570834598.1200001
Debt to equity: 0.9659783272929688
Current ratio: 76.72284554786346
Quick ratio: 76.72284554786346
Interest coverage ratio: -1.5648772592392772
Free cash flow (dilution-adjusted): -2202173.9130434785
Buyback yield (%): 0
Retained earnings: -1571248550.7246377
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7843411072081108
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -4379.56204379562
Operating income: -4583211.678832117
Net income: -11420437.956204379
Capital expenditures: 0
Operating cash flow: -659124.0875912409
Net tangible assets: 129278832.11678831
Owner earnings: -11420437.956204379
Return on net tangible assets (%): -8.83395817335923
Buffett classification: The Gruesome
Stock price: 6.84
Shares outstanding: 438780614
Book value: 129278832.1167883
P/B ratio: 23.21539691083157
Market cap (USD): 3001259399.7599998
Debt to equity: 0.9227776774018701
Current ratio: 26.90680315632331
Quick ratio: 26.90680315632331
Interest coverage ratio: -1.6407107394826235
Free cash flow (dilution-adjusted): -2118978.102189781
Buyback yield (%): 0
Retained earnings: -1594137956.2043793
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8429919928616714
Rule of 40 score: 0
Financial ratios for NG — annual report dated 2025-11-30
Total revenue: 0
Gross profit: -15714.285714285716
Operating income: -18113571.42857143
Net income: -67613571.42857143
Capital expenditures: 0
Operating cash flow: -10020000
Net tangible assets: 116995714.2857143
Owner earnings: -67613571.42857143
Return on net tangible assets (%): -57.79149419392652
Buffett classification: The Gruesome
Stock price: 10.19
Shares outstanding: 438780614
Book value: 116995714.2857143
P/B ratio: 38.21656617045801
Market cap (USD): 4471174456.66
Debt to equity: 1.0199274698706913
Current ratio: 23.792426083434588
Quick ratio: 23.792426083434588
Interest coverage ratio: -1.7164613510220657
Free cash flow (dilution-adjusted): -14802857.142857142
Buyback yield (%): 0
Retained earnings: -1571136428.5714288
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.661907999093587
Rule of 40 score: 0
Financial ratios for NG — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -3571.4285714285716
Operating income: -6055000
Net income: -11158571.42857143
Capital expenditures: 0
Operating cash flow: -4311428.571428572
Net tangible assets: 116995714.2857143
Owner earnings: -11158571.42857143
Return on net tangible assets (%): -9.537589899507918
Buffett classification: The Gruesome
Stock price: 10.19
Shares outstanding: 438780614
Book value: 116995714.2857143
P/B ratio: 38.21656617045801
Market cap (USD): 4471174456.66
Debt to equity: 1.0199274698706913
Current ratio: 23.792426083434588
Quick ratio: 23.792426083434588
Interest coverage ratio: -2.30729450190528
Free cash flow (dilution-adjusted): -5956428.571428572
Buyback yield (%): 0
Retained earnings: -1571136428.5714288
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.561220635999698
Rule of 40 score: 0
Financial ratios for NVVE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3836160
Shares outstanding: 524728
Market cap (USD): 2012940564480
Buyback yield (%): 0.0003983539872709277
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVVE — annual report dated 2022-12-31
Total revenue: 4913956
Gross profit: 717168
Operating income: -36915544
Net income: -24018665
Capital expenditures: 438045
Operating cash flow: -34081975
Depreciation & amortization: 289536
Net tangible assets: 26299425
Owner earnings: -24167174
Return on net tangible assets (%): -91.89240449173319
Buffett classification: The Gruesome
Stock price: 192960
Shares outstanding: 524728
Book value: 27238644
P/B ratio: 3717.20100604127
Market cap (USD): 101251514880
Debt to equity: 0.21713621280119524
Current ratio: 4.032872984422388
Quick ratio: 2.5701507871870146
COGS to revenue (%): 85.40548592620692
R&D to revenue (%): 162.32477458080618
SG&A to revenue (%): 612.8579702382358
Free cash flow (dilution-adjusted): -39754898
Buyback yield (%): 0
Retained earnings: -116956528
Inventory turnover: 0.3633006750185317
Receivables turnover: 4.275604041064961
Capitalized R&D asset: 7976568
ROCI (R&D-adjusted, %): -76.54760194550842
FCF margin (%): -809.0202272873424
Rule of 40 score: -809.0202272873424
Financial ratios for NVVE — annual report dated 2023-12-31
Total revenue: 8005405
Gross profit: 1024061
Operating income: -32105275
Net income: -31284331
Capital expenditures: 188433
Operating cash flow: -21254328
Depreciation & amortization: 396210
Net tangible assets: 6488732
Owner earnings: -31076554
Return on net tangible assets (%): -478.9310762102673
Buffett classification: The Gruesome
Stock price: 36000
Shares outstanding: 524728
Book value: 6990463
P/B ratio: 2702.282810165793
Market cap (USD): 18890208000
Debt to equity: 0.7871628817719227
Current ratio: 1.5680492558349348
Quick ratio: 0.8304774924539025
COGS to revenue (%): 87.20788017595612
R&D to revenue (%): 109.443557196669
SG&A to revenue (%): 308.4752489099552
Free cash flow (dilution-adjusted): -25550395
Buyback yield (%): 0
Retained earnings: -148240859
Inventory turnover: 1.1853976931304147
Receivables turnover: 3.798536842519823
Capitalized R&D asset: 14105700.56
ROCI (R&D-adjusted, %): -106.84087636315202
Rosenberg metric: 0.038474316272361746
FCF margin (%): -319.1643021183813
Revenue growth (%): 62.911613372199504
Rule of 40 score: -256.2526887461818
Financial ratios for NVVE — quarterly report dated 2024-09-30
Capital expenditures: 1527
Buffett classification: The Gruesome
Stock price: 3837.6
Shares outstanding: 524728
Market cap (USD): 2013696172.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVVE — quarterly report dated 2024-12-31
Total revenue: 1699820
Gross profit: 195509
Operating income: -5612341
Net income: -5070008
Capital expenditures: 9235
Operating cash flow: -3491512
Depreciation & amortization: 83696
Net tangible assets: -2323604
Owner earnings: -4995547
Buffett classification: The Gruesome
Stock price: 2246.4
Shares outstanding: 524728
Book value: -1289647
Market cap (USD): 1178748979.2
Debt to equity: -8.263349583258055
Current ratio: 0.8171075585416043
Quick ratio: 0.4125759680201791
COGS to revenue (%): 88.49825275617418
R&D to revenue (%): 45.15525173253639
SG&A to revenue (%): 301.59352166700006
Free cash flow (dilution-adjusted): -4110520
Buyback yield (%): 0
Retained earnings: -165599076
Inventory turnover: 0.3276008503665801
Receivables turnover: 0.6899121324154637
Capitalized R&D asset: 767558
ROCI (R&D-adjusted, %): -82.08016827663212
FCF margin (%): -241.82089868339
Rule of 40 score: -241.82089868339
Financial ratios for NVVE — annual report dated 2024-12-31
Total revenue: 4876252
Gross profit: 1341695
Operating income: -20460431
Net income: -17397603
Capital expenditures: 45395
Operating cash flow: -15734334
Depreciation & amortization: 337971
Net tangible assets: -2323604
Owner earnings: -17105027
Buffett classification: The Gruesome
Stock price: 2246.4
Shares outstanding: 524728
Book value: -1289647
Market cap (USD): 1178748979.2
Debt to equity: -8.263349583258055
Current ratio: 0.8171075585416043
Quick ratio: 0.4125759680201791
Interest coverage ratio: -26.662954000205897
COGS to revenue (%): 72.48511766824191
R&D to revenue (%): 93.12465803654118
SG&A to revenue (%): 362.39123818867444
Free cash flow (dilution-adjusted): -18399856
Buyback yield (%): 0
Retained earnings: -165599076
Inventory turnover: 0.7697370283599257
Receivables turnover: 1.9791421535898914
Capitalized R&D asset: 13043398.44
ROCI (R&D-adjusted, %): -124.4584085127668
Rosenberg metric: 0.03625379505558472
FCF margin (%): -377.33603595548385
Revenue growth (%): -39.08800366752213
Rule of 40 score: -416.42403962300597
Financial ratios for NVVE — quarterly report dated 2025-03-31
Total revenue: 832855
Gross profit: 271611
Operating income: -5586614
Net income: -6873003
Capital expenditures: 12284
Operating cash flow: -1808781
Depreciation & amortization: 72677
Net tangible assets: -4235305
Owner earnings: -6812610
Buffett classification: The Gruesome
Stock price: 1087.2
Shares outstanding: 524728
Book value: -3241806
Market cap (USD): 570484281.6
Debt to equity: -3.0526635461838247
Current ratio: 0.7365698835491362
Quick ratio: 0.40098681904880307
COGS to revenue (%): 67.38796068943573
R&D to revenue (%): 106.11354917722772
SG&A to revenue (%): 609.4580689315667
Free cash flow (dilution-adjusted): -2375724
Buyback yield (%): 0
Retained earnings: -172472079
Inventory turnover: 0.13536300827694855
Receivables turnover: 0.4622236997209525
Capitalized R&D asset: 1398035.86
ROCI (R&D-adjusted, %): -95.16488765092407
Rosenberg metric: 0.099148207692448
FCF margin (%): -285.25061385235125
Revenue growth (%): -51.00334153027968
Rule of 40 score: -336.2539553826309
Financial ratios for NVVE — quarterly report dated 2025-06-30
Total revenue: 332989
Gross profit: 201924
Operating income: -14797225
Net income: -13378800
Capital expenditures: 41889
Operating cash flow: -5465499
Depreciation & amortization: 87748
Net tangible assets: -4450174
Owner earnings: -13332941
Buffett classification: The Gruesome
Stock price: 682.56
Shares outstanding: 524728
Book value: -2828239
Market cap (USD): 358158343.67999995
Debt to equity: -3.5573461083027285
Current ratio: 0.661126978578317
Quick ratio: 0.33993240820278803
COGS to revenue (%): 39.36015904429275
R&D to revenue (%): 328.2880215262366
SG&A to revenue (%): 4176.109721342146
Free cash flow (dilution-adjusted): -5521410
Buyback yield (%): 0
Retained earnings: -185850879
Inventory turnover: 0.030715355029336193
Receivables turnover: 0.9531645823255122
Capitalized R&D asset: 1938584.38
ROCI (R&D-adjusted, %): -258.8827145191913
Rosenberg metric: -0.07885178530209148
FCF margin (%): -1658.1358543375306
Revenue growth (%): -60.01837054469266
Rule of 40 score: -1718.1542248822234
Financial ratios for NVVE — quarterly report dated 2025-09-30
Total revenue: 1328437
Gross profit: 561461
Operating income: -5111271
Net income: -4507260
Capital expenditures: 2926
Operating cash flow: -5073704
Depreciation & amortization: 85371
Net tangible assets: -2606501
Owner earnings: -4424815
Buffett classification: The Gruesome
Stock price: 169.2
Shares outstanding: 524728
Book value: -1918477
Market cap (USD): 88783977.6
Debt to equity: -3.960108461034456
Current ratio: 0.738079599475315
Quick ratio: 0.40931185278285553
COGS to revenue (%): 57.735218154869216
R&D to revenue (%): 88.77259516258582
SG&A to revenue (%): 358.5893798501547
Free cash flow (dilution-adjusted): -5322254
Buyback yield (%): 0
Retained earnings: -190358139
Inventory turnover: 0.18024792267756679
Receivables turnover: 1.1975938805775048
Capitalized R&D asset: 2203351.9699999997
ROCI (R&D-adjusted, %): -82.84380628645735
Rosenberg metric: 0.32889605667224375
FCF margin (%): -400.6403013466201
Revenue growth (%): 298.9432083342092
Rule of 40 score: -101.6970930124109
Financial ratios for NVVE — quarterly report dated 2025-12-31
Total revenue: 1740450
Gross profit: 278459
Operating income: -3215075
Net income: -6063488
Capital expenditures: 0
Operating cash flow: -4279143
Depreciation & amortization: 83704
Net tangible assets: -2834793
Owner earnings: -5979784
Buffett classification: The Gruesome
Stock price: 45.72
Shares outstanding: 524728
Book value: 2530543
P/B ratio: 9.480401700346526
Market cap (USD): 23990564.16
Debt to equity: 2.4297283231306483
Current ratio: 1.1279288086625476
Quick ratio: 1.046070484804847
COGS to revenue (%): 84.00074693326438
R&D to revenue (%): 38.74342842368353
SG&A to revenue (%): 174.0144790140481
Free cash flow (dilution-adjusted): -5896970
Buyback yield (%): 0
Retained earnings: -196421627
Inventory turnover: 1.825619771758662
Receivables turnover: 0.7248036560638096
Capitalized R&D asset: 1825176.75
ROCI (R&D-adjusted, %): -37.33882294850835
Rosenberg metric: -0.23997700307304068
FCF margin (%): -338.81869631417163
Revenue growth (%): 31.01486935398517
Rule of 40 score: -307.8038269601865
Financial ratios for NVVE — annual report dated 2025-12-31
Total revenue: 4234731
Gross profit: 1313455
Operating income: -28710185
Net income: -30822551
Capital expenditures: 57099
Operating cash flow: -16627127
Depreciation & amortization: 329500
Net tangible assets: -2834793
Owner earnings: -30550150
Buffett classification: The Gruesome
Stock price: 45.72
Shares outstanding: 524728
Book value: 2530543
P/B ratio: 9.480401700346526
Market cap (USD): 23990564.16
Debt to equity: 2.4297283231306483
Current ratio: 1.1279288086625476
Quick ratio: 1.046070484804847
Interest coverage ratio: -14.679652271905699
COGS to revenue (%): 68.98374418587628
R&D to revenue (%): 90.4551670460296
SG&A to revenue (%): 631.7359473364423
Free cash flow (dilution-adjusted): -19116358
Buyback yield (%): 0
Retained earnings: -196421627
Inventory turnover: 3.647860502810248
Receivables turnover: 1.763537310032895
Capitalized R&D asset: 9764260.31
ROCI (R&D-adjusted, %): -176.0677176728446
Rosenberg metric: -0.00621890410313339
FCF margin (%): -451.418472625534
Revenue growth (%): -13.156026390760772
Rule of 40 score: -464.57449901629474
Financial ratios for NYXH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23
Shares outstanding: 100072815
Market cap (USD): 2301674745
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NYXH — annual report dated 2022-12-31
Total revenue: 3280851.0638297875
Gross profit: 2057446.8085106383
Operating income: -34573404.25531915
Net income: -33218085.10638298
Capital expenditures: 942553.1914893618
Operating cash flow: -30591489.36170213
Depreciation & amortization: 2055319.1489361704
Net tangible assets: 85480851.0638298
Owner earnings: -32105319.14893617
Return on net tangible assets (%): -37.55849263241736
Buffett classification: The Gruesome
Stock price: 4.99
Shares outstanding: 100072815
Book value: 128004255.31914896
P/B ratio: 3.9011464548967782
Market cap (USD): 499363346.85
Debt to equity: 0.09875835244838935
Current ratio: 6.72299336149668
Quick ratio: 6.663850331925166
Interest coverage ratio: -137.126582278481
COGS to revenue (%): 37.28923476005188
R&D to revenue (%): 514.2996108949416
SG&A to revenue (%): 581.7444876783397
Free cash flow (dilution-adjusted): -50854255.319148935
Buyback yield (%): 0
Retained earnings: -125757446.80851065
Inventory turnover: 1.3038548752834467
Receivables turnover: 0.9527340129749768
Capitalized R&D asset: 16873404.25531915
ROCI (R&D-adjusted, %): -14.913038450812477
FCF margin (%): -1550.0324254215304
Rule of 40 score: -1550.0324254215304
Financial ratios for NYXH — annual report dated 2023-12-31
Total revenue: 4831111.111111111
Gross profit: 2991111.111111111
Operating income: -50113333.333333336
Net income: -48013333.333333336
Capital expenditures: 2777777.7777777775
Operating cash flow: -49753333.333333336
Depreciation & amortization: 2622222.222222222
Net tangible assets: 57126666.666666664
Owner earnings: -48168888.88888889
Return on net tangible assets (%): -84.31944606527405
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 100072815
Book value: 108913333.33333331
P/B ratio: 4.263370217298157
Market cap (USD): 464337861.59999996
Debt to equity: 0.1296035583848524
Current ratio: 4.7324655542477325
Quick ratio: 4.502942601952503
Interest coverage ratio: -207.84331797235026
COGS to revenue (%): 38.086476540938364
R&D to revenue (%): 612.9484820607175
SG&A to revenue (%): 474.8160073597056
Free cash flow (dilution-adjusted): -64834444.44444444
Buyback yield (%): 0
Retained earnings: -178698888.8888889
Inventory turnover: 0.49954751131221725
Receivables turnover: 0.7727030389194953
Capitalized R&D asset: 40917403.07328605
ROCI (R&D-adjusted, %): -22.10779479887576
Rosenberg metric: 0.05533348744999964
FCF margin (%): -1342.0193192272309
Revenue growth (%): 47.25176538406109
Rule of 40 score: -1294.7675538431697
Financial ratios for NYXH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.55
Shares outstanding: 100072815
Market cap (USD): 955695383.2500001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NYXH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 100072815
Market cap (USD): 800582520
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NYXH — annual report dated 2024-12-31
Total revenue: 4709375
Gross profit: 3092708.3333333335
Operating income: -61259375
Net income: -61704166.66666667
Capital expenditures: 1206250
Operating cash flow: -51277083.333333336
Depreciation & amortization: 2831250
Net tangible assets: 65492708.333333336
Owner earnings: -60079166.66666667
Return on net tangible assets (%): -91.73413070793505
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 100072815
Book value: 117972916.66666666
P/B ratio: 6.7861551839228635
Market cap (USD): 800582520
Debt to equity: 0.20001942536245962
Current ratio: 4.555854893399601
Quick ratio: 4.336801523526407
Interest coverage ratio: -66.37584650112866
COGS to revenue (%): 34.328688343286885
R&D to revenue (%): 759.2346825923469
SG&A to revenue (%): 601.1280690112807
Free cash flow (dilution-adjusted): -61735416.66666667
Buyback yield (%): 0
Retained earnings: -226807291.6666667
Inventory turnover: 0.3290924512298558
Receivables turnover: 0.7339285714285714
Capitalized R&D asset: 61163620.62647754
ROCI (R&D-adjusted, %): -25.9727023588674
Rosenberg metric: 0.003430921916626027
FCF margin (%): -1310.9046671090468
Revenue growth (%): -2.5198367065317364
Rule of 40 score: -1313.4245038155786
Financial ratios for NYXH — quarterly report dated 2025-03-31
Total revenue: 1156521.7391304348
Gross profit: 715217.3913043478
Operating income: -22433695.65217391
Net income: -24330434.782608695
Capital expenditures: 228260.86956521738
Operating cash flow: -20133695.652173914
Depreciation & amortization: 841304.3478260869
Net tangible assets: 45506521.73913043
Owner earnings: -23717391.304347828
Return on net tangible assets (%): -52.11866430994125
Buffett classification: The Gruesome
Stock price: 6.98
Shares outstanding: 100072815
Book value: 100916304.34782608
P/B ratio: 6.921659024417566
Market cap (USD): 698508248.7
Debt to equity: 0.20934265372726002
Current ratio: 3.586210185008583
Quick ratio: 3.348703032614915
Interest coverage ratio: -29.739193083573483
COGS to revenue (%): 38.1578947368421
R&D to revenue (%): 844.8308270676691
SG&A to revenue (%): 1130.545112781955
Free cash flow (dilution-adjusted): -23447826.08695652
Buyback yield (%): 0
Retained earnings: -260978260.86956522
Inventory turnover: 0.08150973700060228
Receivables turnover: 0.19494320263832907
Capitalized R&D asset: 9770652.173913043
ROCI (R&D-adjusted, %): -11.819184420055949
FCF margin (%): -2027.443609022556
Rule of 40 score: -2027.443609022556
Financial ratios for NYXH — quarterly report dated 2025-06-30
Total revenue: 1576470.5882352942
Gross profit: 1000000
Operating income: -23352941.17647059
Net income: -24243529.411764707
Capital expenditures: 648235.2941176471
Operating cash flow: -19682352.94117647
Depreciation & amortization: 910588.2352941177
Net tangible assets: 25870588.23529412
Owner earnings: -23981176.470588237
Return on net tangible assets (%): -92.69668030923147
Buffett classification: The Gruesome
Stock price: 7.48
Shares outstanding: 100072815
Book value: 86349411.7647059
P/B ratio: 8.66878697726065
Market cap (USD): 748544656.2
Debt to equity: 0.2684850879463738
Current ratio: 2.631242241955505
Quick ratio: 2.3766828988828417
Interest coverage ratio: -29.320531757754804
COGS to revenue (%): 36.56716417910447
R&D to revenue (%): 750.6716417910447
SG&A to revenue (%): 769.8507462686566
Free cash flow (dilution-adjusted): -22183529.411764707
Buyback yield (%): 0
Retained earnings: -306130588.2352941
Inventory turnover: 0.09189797449362341
Receivables turnover: 0.23712617235887454
Capitalized R&D asset: 18380454.603580564
ROCI (R&D-adjusted, %): -14.316442304942942
Rosenberg metric: 0.029146734898208928
FCF margin (%): -1407.1641791044776
Revenue growth (%): 36.31136665192393
Rule of 40 score: -1370.8528124525537
Financial ratios for NYXH — quarterly report dated 2025-09-30
Total revenue: 2320000
Gross profit: 1403529.411764706
Operating income: -28464705.88235294
Net income: -27741176.470588237
Capital expenditures: 23529.411764705885
Operating cash flow: -24100000
Depreciation & amortization: 1694117.6470588236
Net tangible assets: 995294.1176470588
Owner earnings: -26070588.235294122
Return on net tangible assets (%): -2619.385342789599
Buffett classification: The Gruesome
Stock price: 4.6
Shares outstanding: 100072815
Book value: 59945882.352941185
P/B ratio: 7.679175465125405
Market cap (USD): 460334948.99999994
Debt to equity: 0.38210935353456055
Current ratio: 1.702635001686016
Quick ratio: 1.409990847343321
Interest coverage ratio: -34.56428571428571
COGS to revenue (%): 39.503042596348884
R&D to revenue (%): 654.7160243407708
SG&A to revenue (%): 614.3509127789047
Free cash flow (dilution-adjusted): -25688235.29411765
Buyback yield (%): 0
Retained earnings: -332692941.1764706
Inventory turnover: 0.1282304526748971
Receivables turnover: 0.4380275433140826
Capitalized R&D asset: 26342585.8056266
ROCI (R&D-adjusted, %): -22.79611995515279
Rosenberg metric: 0.03409881697981908
FCF margin (%): -1107.2515212981746
Revenue growth (%): 47.164179104477604
Rule of 40 score: -1060.087342193697
Financial ratios for NYXH — annual report dated 2025-12-31
Total revenue: 11788235.294117648
Gross profit: 7442352.94117647
Operating income: -97578823.52941176
Net income: -105982352.94117647
Capital expenditures: 943529.4117647059
Operating cash flow: -81151764.70588236
Depreciation & amortization: 5275294.117647059
Net tangible assets: -1151764.705882353
Owner earnings: -101650588.23529413
Buffett classification: The Gruesome
Stock price: 4.6
Shares outstanding: 100072815
Book value: 57798823.52941176
P/B ratio: 7.9644345834435875
Market cap (USD): 460334948.99999994
Debt to equity: 0.823851493008203
Current ratio: 1.250316597900241
Quick ratio: 1.1551329711181013
Interest coverage ratio: -49.04908338261384
COGS to revenue (%): 36.86626746506986
R&D to revenue (%): 427.38522954091815
SG&A to revenue (%): 463.4431137724551
Free cash flow (dilution-adjusted): -91334117.64705883
Buyback yield (%): 0
Retained earnings: -360034117.64705884
Inventory turnover: 0.7927038626609443
Receivables turnover: 1.3222486144101346
Capitalized R&D asset: 84109199.38725491
ROCI (R&D-adjusted, %): -51.70952442014652
Rosenberg metric: 0.12165065764106077
FCF margin (%): -774.7904191616766
Revenue growth (%): 150.31421991490691
Rule of 40 score: -624.4761992467697
Financial ratios for NYXH — quarterly report dated 2025-12-31
Total revenue: 6640000
Gross profit: 4264705.882352942
Operating income: -21481176.470588237
Net income: -27662352.94117647
Capital expenditures: 24705.88235294118
Operating cash flow: -15577647.05882353
Depreciation & amortization: 1760000
Net tangible assets: -1151764.705882353
Owner earnings: -25927058.82352941
Buffett classification: The Gruesome
Stock price: 4.6
Shares outstanding: 100072815
Book value: 57798823.52941176
P/B ratio: 7.9644345834435875
Market cap (USD): 460334948.99999994
Debt to equity: 0.823851493008203
Current ratio: 1.250316597900241
Quick ratio: 1.1551329711181013
COGS to revenue (%): 35.77250177179305
R&D to revenue (%): 192.5053153791637
SG&A to revenue (%): 212.20765414599578
Free cash flow (dilution-adjusted): -18083529.411764707
Buyback yield (%): 0
Retained earnings: -360034117.64705884
Inventory turnover: 0.4332618025751073
Receivables turnover: 0.7447875428873053
Capitalized R&D asset: 26864517.647058826
ROCI (R&D-adjusted, %): -20.219566947460095
Rosenberg metric: 0.18836650917822012
FCF margin (%): -272.3423104181432
Revenue growth (%): 186.20689655172413
Rule of 40 score: -86.13541386641907
Financial ratios for PHOR.L — annual report dated 2021-12-31
Total revenue: 568227027027.027
Gross profit: 272541891891.8919
Operating income: 221852702702.7027
Net income: 175266216216.21622
Capital expenditures: 64798648648.64865
Operating cash flow: 170574324324.32434
Depreciation & amortization: 37400000000
Net tangible assets: 219974324324.32434
Owner earnings: 147867567567.56757
Return on net tangible assets (%): 67.22037584238946
Capex to operating income (%): 29.207959992934196
Buffett classification: The Good
Stock price: 0.29162162162162164
P/E ratio: 0.0006464815525910392
Shares outstanding: 388539008
Book value: 222490540540.5406
P/B ratio: 0.000509263788478101
Market cap (USD): 113306375.57621622
Debt to equity: 1.0655053661558642
Current ratio: 1.9161129943502824
Quick ratio: 1.2957438794726928
Effective tax rate (%): 18.981600074974224
Interest coverage ratio: 37.71444980473237
COGS to revenue (%): 52.03644337055992
SG&A to revenue (%): 1.7803123989269616
Free cash flow (dilution-adjusted): 105775675675.67567
Buyback yield (%): 0
Retained earnings: 200260810810.81082
Inventory turnover: 5.313815965223304
Receivables turnover: 12.737042983067274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.41774018497546
FCF margin (%): 18.61503776564373
Rule of 40 score: 18.61503776564373
Financial ratios for PRM.AX — annual report dated 2021-06-30
Operating income: -553028.5714285714
Net income: 906490.2255639097
Capital expenditures: 240404.51127819548
Net tangible assets: 2161839.0977443606
Owner earnings: 666085.7142857143
Return on net tangible assets (%): 30.811067992095293
Buffett classification: The Gruesome
Stock price: 0.18045112781954886
P/E ratio: 532.5938188767385
Shares outstanding: 2675467296
Book value: 2161839.097744361
P/B ratio: 223.3242480956412
Market cap (USD): 482791091.00751877
Debt to equity: 0.0015066536915450015
Current ratio: 2.102802016935838
Quick ratio: 2.102802016935838
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -870332.3308270676
Buyback yield (%): 0.027227798090540864
Retained earnings: -114574953.38345864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.58139373117987
Rule of 40 score: 0
Financial ratios for PRM.AX — annual report dated 2022-06-30
Operating income: -7533582.068965518
Net income: -7389743.448275862
Capital expenditures: 8635111.034482758
Net tangible assets: 5854364.137931035
Owner earnings: -16024854.48275862
Return on net tangible assets (%): -273.7249358804301
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 2675467296
Book value: 5854364.137931035
P/B ratio: 12.607004387413669
Market cap (USD): 73805994.3724138
Debt to equity: 0
Current ratio: 3.6326527708952265
Quick ratio: 3.6326527708952265
Interest coverage ratio: -67.45810921800992
Free cash flow (dilution-adjusted): -9252097.241379311
Buyback yield (%): 0.5868133773667327
Retained earnings: -112456424.8275862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -128.68318217779887
Rule of 40 score: 0
Financial ratios for PRM.AX — annual report dated 2023-06-30
Operating income: -665058.2781456953
Net income: -648800
Capital expenditures: 882768.2119205298
Net tangible assets: 4978018.543046358
Owner earnings: -1531568.2119205298
Return on net tangible assets (%): -30.76662327945585
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 2675467296
Book value: 4978018.543046358
P/B ratio: 7.118626140244635
Market cap (USD): 35436652.92715232
Debt to equity: 0
Current ratio: 1.236710727675556
Quick ratio: 1.236710727675556
Interest coverage ratio: -91294.36363636363
Free cash flow (dilution-adjusted): -1513392.715231788
Buyback yield (%): 0
Retained earnings: -108636757.61589403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.359899574393811
Rule of 40 score: 0
Financial ratios for PTM.TO — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.698412698412698
Shares outstanding: 127885112
Market cap (USD): 345086810.15873015
Buyback yield (%): 0.03472786160275041
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PTM.TO — annual report dated 2022-08-31
Total revenue: 0
Gross profit: -69465.64885496182
Operating income: -4965648.854961832
Net income: -6292366.41221374
Capital expenditures: 2564122.13740458
Operating cash flow: -3411450.381679389
Depreciation & amortization: 69465.64885496182
Net tangible assets: 24809923.66412214
Owner earnings: -8787022.900763359
Return on net tangible assets (%): -35.41737177317621
Buffett classification: The Gruesome
Stock price: 1.4885496183206106
Shares outstanding: 127885112
Book value: 39354961.83206107
P/B ratio: 4.837085993599069
Market cap (USD): 190363334.65648854
Debt to equity: 0.0008534574726020755
Current ratio: 11.386262265834079
Quick ratio: 11.386262265834079
Interest coverage ratio: -3.9424242424242424
Free cash flow (dilution-adjusted): -7627480.916030534
Buyback yield (%): 0
Retained earnings: -586562595.4198472
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.37680277027284
Rule of 40 score: 0
Financial ratios for PTM.TO — annual report dated 2023-08-31
Total revenue: 0
Gross profit: -61481.481481481474
Operating income: -4351851.851851852
Net income: -4194814.814814814
Capital expenditures: 3293333.333333333
Operating cash flow: -2807407.407407407
Depreciation & amortization: 61481.481481481474
Net tangible assets: 19058518.51851852
Owner earnings: -7426666.666666666
Return on net tangible assets (%): -38.96770181507248
Buffett classification: The Gruesome
Stock price: 1.222222222222222
Shares outstanding: 127885112
Book value: 35091851.85185185
P/B ratio: 4.454140135939545
Market cap (USD): 156304025.77777776
Debt to equity: 0.0066914341199814245
Current ratio: 5.524506217995611
Quick ratio: 5.524506217995611
Free cash flow (dilution-adjusted): -7568148.148148148
Buyback yield (%): 0.018956408500798938
Retained earnings: -573877777.7777778
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.075060632219344
Rule of 40 score: 0
Financial ratios for PTM.TO — annual report dated 2024-08-31
Total revenue: 0
Gross profit: -53333.33333333333
Operating income: -3662222.222222222
Net income: -3412592.5925925924
Capital expenditures: 2534814.814814815
Operating cash flow: -1880740.7407407407
Depreciation & amortization: 53333.33333333333
Net tangible assets: 19811851.85185185
Owner earnings: -5894074.074074074
Return on net tangible assets (%): -29.75024302699469
Buffett classification: The Gruesome
Stock price: 1.2666666666666666
Shares outstanding: 127885112
Book value: 36851851.85185185
P/B ratio: 4.395649075778894
Market cap (USD): 161987808.53333333
Debt to equity: 0.00528643216080402
Current ratio: 4.67292817679558
Quick ratio: 4.67292817679558
Free cash flow (dilution-adjusted): -5424444.444444444
Buyback yield (%): 0.048929150889123564
Retained earnings: -577779259.2592592
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.658513714151756
Rule of 40 score: 0